RP Bio Inc. (KOSDAQ:314140)

RP Bio Revenue

RP Bio had revenue of 39.77B KRW in the quarter ending June 30, 2026, with 11.40% growth. This brings the company's total for the last twelve months to 141.42B, up 9.55% year-over-year. In the year 2025, RP Bio had annual revenue of 136.22B with 9.88% growth. That makes RP Bio the 22,147th largest company in the world by revenue and 1,237th in South Korea.

• Revenue (ttm): 141.42B
• Revenue Growth: +9.55%
• P/S Ratio: 0.33
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 47.06B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Health Functional Food 71.86B 58.0%
• Medicines 51.47B 41.5%
• Raw Materials, etc. 332.92M 0.3%
• Other 303.20M 0.2%

By Geography

• South Korea 122.59B 98.9%
• Other 1.38B 1.1%

Fiscal year ended Dec 31, 2024 See the full RP Bio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	136.22B	12.25B	9.88%
Dec 31, 2024	123.97B	-27.08B	-17.93%
Dec 31, 2023	151.05B	12.94B	9.37%
Dec 31, 2022	138.11B	23.15B	20.13%
Dec 31, 2021	114.96B	17.04B	17.40%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error